Status:
COMPLETED
Midodrine for Improving Hemodynamics After Spinal Anesthesia
Lead Sponsor:
Mansoura University
Conditions:
Hypotension After Spinal Anesthesia
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Neuraxial blockade such as spinal anaesthesia can cause severe hypotension due to pharmacological sympathectomy resulting in potential deleterious consequences for the patient. Prevention of this spin...
Detailed Description
Neuraxial blockade such as spinal anaesthesia can cause severe hypotension due to pharmacological sympathectomy resulting in potential deleterious consequences for the patient. Prevention of this spin...
Eligibility Criteria
Inclusion
- • American Society of Anesthesiologists (ASA) status: 1 or 2 .
- Orthopedic surgery on the lower extremities
Exclusion
- • Pheochromocytoma. .Throtoxicosis. .Structural heart disease.
- Baseline blood pressure more than 140/90 .Acute kidney failure.
- Any contraindications to spinal anesthesia such as local infection and coagulopathy
Key Trial Info
Start Date :
June 8 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 29 2020
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT04396548
Start Date
June 8 2020
End Date
December 29 2020
Last Update
January 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mansoura university hospital
Al Mansurah, Egypt